Cadila receives USFDA approval for Pindolol tablets

Zydus Cadila has received final USFDA approval to market Pindolol tablets in USA, which is used for treatment of hypertension. The company will market the drug in the strengths of 5 mg and 10 mg. Pindolol belongs to a class of beta-blockers and is used to treat hypertension. The company will manufacture the drug at the groups manufacturing facility at the Pharma SEZ in Ahmedabad.

Company Profile : Cadila Healthcare Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.


*